BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
December 16, 2024
BOTHELL, Wash. -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J. Hunt, Executive Chairman of Repligen Corporation (Nasdaq: RGEN) and a recognized leader in bioprocessing innovation, to its board of directors effective January 2, 2025. [...]
bit.bio Raises $30 Million Led by M&G Investments
December 16, 2024
bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets. Jonathan Milner Appointed Interim CEO; Mark Kotter Assumes Vice Chairman Role as Company Expands Board with Distinguished Biotech Leaders. Cambridge, UK – bit.bio, the global leader in cell programming technology, today announced the successful [...]
December 16, 2024
Shimadzu Corporation has signed an investment contract with U-Medico Inc, (head office: Osaka prefecture; hereinafter U-Medico), a contract research organization (CRO). In accordance with this investment, from December 2024, Shimadzu has collaboratively developed a gene therapy pharmaceuticals manufacturing platform aimed at pharmaceutical companies, contract development and manufacturing organizations (CDMO), and educational & research institutions, and [...]
December 16, 2024
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today announced that NF Validation (AFNOR) has approved the extension of certification of the iQ-Check™ Listeria spp. and iQ-Check™ Listeria monocytogenes Kits for the real-time PCR detection of Listeria spp. and Listeria monocytogenes in food products for human consumption and in environmental samples [...]
December 15, 2024
A groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness. SequenceME will bring together experts from Oxford Nanopore Technologies, Action for ME, and the University of Edinburgh, to uncover the root causes of ME and to [...]
Sepragen Corporation Receives ISO 9001:2015 Certification
December 13, 2024
UNION CITY, Calif. -- Sepragen Corporation, a leader in innovative bioprocessing technologies, is proud to announce that it has achieved ISO 9001:2015 certification, the internationally recognized standard for quality management systems. This milestone demonstrates Sepragen’s unwavering commitment to delivering high-quality products and services that meet the rigorous standards of the bioprocessing industry. The ISO 9001:2015 [...]
LECO Announces Metabolomics Training Collaboration in the UK
December 13, 2024
LECO Instruments UK Ltd., a subsidiary of USA-based LECO Corporation, is pleased to announce a new and exciting training and research collaboration with the Liverpool Training Centre for Metabolomics and Centre for Metabolomics Research at the University of Liverpool. These centers are internationally recognized for their expertise in the development of analytical chemistry and software [...]
December 12, 2024
SAN DIEGO, Calif. – Quantum Design (QD) is very excited to announce the appointment of its new global Chief Executive Officer – Stuart Schoenmann. Mr. Schoenmann has several decades worth of experience leading technology companies through periods of successful growth and expansion. With knowledge in areas such as life science instrumentation, non-contact infrared measurement devices, [...]
DPBIO and Leveragen Announce Strategic Partnership to Advance Antibody Discovery
December 12, 2024
BOSTON -- Dapu Biotechnology (DPBIO), an industry leader in droplet microfluidic technology, and Leveragen, Inc., a Boston-based biotech developing advanced genetic models for antibody discovery, have announced a strategic partnership to accelerate innovations in antibody drug development. The collaboration brings together DPBIO’s Cytospark™ droplet microfluidic single-B cell antibody discovery platform and Leveragen’s Singularity Sapiens Mouse, a next-generation [...]
December 12, 2024
Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology AI-extension highlights key biological elements at work and provides summarized results and interpretations in a sharable web document, speeding up interpretation Ingenuity Pathway Analysis Interpret unlocks the full potential of biological data by streamlining interpretation process and delivering actionable insights for [...]

